“Pharma Bro” Martin Shkreli filed motions in May to dismiss the FTC’s claims that his company Vyera Pharmaceuticals boxed out competition and created a monopoly for the toxoplasmosis drug Daraprim after raising prices by 4,000% overnight. But on Tuesday, a federal judge said not so fast.
Copyright © 2021,